Ledger.Open graph →
SEC Form D · filed May 6, 2025

OncoResponse, Inc

Offering
—
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HOUSTON, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Sean A. Mccarthy · South San Francisco, CADirectorRoberto D. De Ponti · HOUSTON, TXDirectorSteven D. Gillis · HOUSTON, TXDirectorClifford J. Stocks · Houston, TXExec · DirectorJohn A. Mckearn · HOUSTON, TXDirectorAlice J. Bexon · HOUSTON, TXExecKamal D. Puri · HOUSTON, TXExecCarol D. Gallagher · HOUSTON, TXDirectorChris D. Russell · HOUSTON, TXExecWende D. Hutton · HOUSTON, TXDirectorSean A. Mccarthy · South San Francisco, CADirectorRoberto D. De Ponti · HOUSTON, TXDirectorAlice J. Bexon · HOUSTON, TXExecSteven D. Gillis · HOUSTON, TXDirectorClifford J. Stocks · Houston, TXExec · DirectorKamal D. Puri · HOUSTON, TXExecCarol D. Gallagher · HOUSTON, TXDirectorJohn A. Mckearn · HOUSTON, TXDirectorChris D. Russell · HOUSTON, TXExecWende D. Hutton · HOUSTON, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗